indazoles has been researched along with Malignant Fibrohistiocytic Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Fujita, H; Oda, K; Sato, M; Wada, H | 1 |
| Abe, K; Hayashi, K; Higuchi, T; Inatani, H; Miwa, S; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N | 1 |
2 other study(ies) available for indazoles and Malignant Fibrohistiocytic Tumors
| Article | Year |
|---|---|
Pazopanib-induced leg ulcer in a patient with malignant fibrous histiocytoma.
Topics: Aged, 80 and over; Female; Histiocytoma, Malignant Fibrous; Humans; Indazoles; Leg Ulcer; Protein-Tyrosine Kinases; Pyrimidines; Soft Tissue Neoplasms; Sulfonamides | 2014 |
Balancing Prolonged Survival with QoL Using Low-dose Pazopanib Maintenance: A Comparison with the PALETTE Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Histiocytoma, Malignant Fibrous; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Quality of Life; Retrospective Studies; Sarcoma; Sulfonamides | 2016 |